These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30769242)

  • 21. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From fragment to clinical candidate--a historical perspective.
    Chessari G; Woodhead AJ
    Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benefits of constructing leads from fragment hits.
    Foloppe N
    Future Med Chem; 2011 Jul; 3(9):1111-5. PubMed ID: 21806375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and screening of small-molecule Ī±-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators.
    Tang C; Niu Q; Cicka D; Du Y; Mo X; Fu H
    STAR Protoc; 2021 Sep; 2(3):100804. PubMed ID: 34527960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the fragment-based drug discovery].
    Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
    Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 14-3-3: A Case Study in PPI Modulation.
    Ballone A; Centorrino F; Ottmann C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interfering peptides targeting protein-protein interactions: the next generation of drugs?
    Bruzzoni-Giovanelli H; Alezra V; Wolff N; Dong CZ; Tuffery P; Rebollo A
    Drug Discov Today; 2018 Feb; 23(2):272-285. PubMed ID: 29097277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein-protein interactions as druggable targets: recent technological advances.
    Higueruelo AP; Jubb H; Blundell TL
    Curr Opin Pharmacol; 2013 Oct; 13(5):791-6. PubMed ID: 23735579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Databases of protein-protein interactions and their use in drug discovery.
    Fuentes G; Oyarzabal J; Rojas AM
    Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational methods-guided design of modulators targeting protein-protein interactions (PPIs).
    Qiu Y; Li X; He X; Pu J; Zhang J; Lu S
    Eur J Med Chem; 2020 Dec; 207():112764. PubMed ID: 32871340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
    Magee TV
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
    Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.
    Svensson F; Bender A; Bailey D
    J Med Chem; 2018 Feb; 61(4):1415-1424. PubMed ID: 28800229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The present and the future of motif-mediated protein-protein interactions.
    Seo MH; Kim PM
    Curr Opin Struct Biol; 2018 Jun; 50():162-170. PubMed ID: 29730529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of modulators of protein-protein interactions: current approaches and limitations.
    Meireles LM; Mustata G
    Curr Top Med Chem; 2011; 11(3):248-57. PubMed ID: 21320056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulating protein-protein interactions: the potential of peptides.
    Nevola L; Giralt E
    Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies to Develop Inhibitors of Motif-Mediated Protein-Protein Interactions as Drug Leads.
    Corbi-Verge C; Garton M; Nim S; Kim PM
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():39-60. PubMed ID: 27618737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.